Page components

About cITP

Chronic immune thrombocytopenia, or cITP, is a disorder that can lead to excessive bruising or bleeding.

What is cITP image

What is cITP?

cITP can develop when your immune system attacks certain blood cells (platelets) in your blood. Platelets help the blood to clot. Patients with cITP have low levels of platelets and are at risk of excessive bruising or bleeding.

How cITP is treated

cITP is typically treated by stopping the destruction of platelet counts with an intravenous immunoglobulin (IVIg), such as PANZYGA.

A nurse or other member of your care team will administer PANZYGA through an infusion in a vein, which can occur in a hospital, an infusion clinic, or at home.

What is cITP image

*Eligible, commercially insured patients may pay as little as $0 for PANZYGA and may receive a maximum benefit of $12,500 per year or the cost of patient’s co-pay in a 12-month period (whichever is less) for claims received by the program. Terms and conditions/eligibility requirements apply. See full terms and conditions at

- Patients must have commercial insurance to be eligible

- Patients are not eligible if they are enrolled in a state or federally funded insurance program